The pharma services sector is a hotbed for investment, according to Jay Ferguson, director at Houlihan Lokey's Healthcare Group. He predicts a surge in demand driven by a confluence of
News & Updates
The pharmaceutical industry is on the cusp of a major transformation driven by digitalization. This era, known as Pharma 4.0 or the "Smart Factory," leverages cutting-edge technologies like Artificial Intelligence
Lykos Therapeutics (formerly MAPS Public Benefit Corporation) announced the successful completion of their Phase 2 study (MP18) in Europe. This open-label study examined the feasibility and safety of using MDMA
Endevica Bio, a company specializing in peptide-based drugs, announced positive results from a recent study on their novel weight-loss treatment. This study, conducted on rats with diet-induced obesity (DIO), utilized
Researchers from MIT, the Broad Institute, and Massachusetts General Hospital have developed an AI tool called Tyche to address a key limitation in current medical image analysis. While existing AI
The pharmaceutical industry is at a critical juncture. Leading companies like Bristol Myers Squibb, Merck, Pfizer, and Johnson & Johnson are facing a period of patent expirations for their blockbuster
A large-scale study funded by the National Institutes of Health (NIH) has found no causal link between acetaminophen exposure during pregnancy and an increased risk of neurodevelopmental disorders in children,
Researchers at Johns Hopkins Kimmel Cancer Center are showing positive progress in developing a personalized vaccine for liver cancer. This early-stage clinical trial offers a potential new approach to treating
A recent clinical trial funded by the National Heart, Lung, and Blood Institute (NHLBI) shows promise for treating a rare and painful genetic disease called Arterial Calcification Due to Deficiency
A University of Liverpool project has received a significant boost in its fight against major diseases. Unitaid, a global health organization, awarded over £6 million to the initiative, titled LONGEVITY.
Cadrenal Therapeutics' Tecarfarin Scores Orphan Drug Designation for Preventing Blood Clots in Heart Assist Device Patients Cadrenal Therapeutics, a biopharmaceutical company developing innovative blood thinners, recently announced a significant development
Every year, the issue of executive compensation in Big Pharma comes under close scrutiny. This year is no different, as publicly traded companies reveal the total compensation packages for their